HARE Activators consist of a diverse array of chemical compounds that indirectly influence the functional activity of HARE through modulation of intricate cellular signaling pathways. Forskolin, for example, effectively raises intracellular cAMP, which in turn activates PKA, a kinase that can phosphorylate specific substrates instrumental in enhancing endocytic pathways where HARE functions. Similarly, agents like Genistein, by inhibiting competitive tyrosine kinase signaling, allow for an augmentation of HARE's role in receptor-mediated endocytosis. Phorbol esters such as PMA activate PKC, which phosphorylates regulatory proteins in endocytosis, potentially increasing HARE activity. Disruption of intracellular calcium dynamics also plays a role; compounds like A23187 and Thapsigargin elevate cytosolic calcium, which is pivotal for activating calcium-dependent signaling pathways, indirectly enhancing HARE's role in vesicle trafficking and receptor turnover.
Additionally, HARE's endocytic capabilities are potentially amplified by compounds modifying lipid signaling, such as Sphingosine-1-phosphate, which modulates receptor recycling, a key aspect of HARE's functionality. PI3K inhibitors, including LY294002 and Wortmannin, might shift signaling dynamics to favor endocytic pathways where HARE is more active. This theoretical enhancement is further supported by the inhibitory actions of IBMX on phosphodiesterases, which boost PKA and PKG levels, and U73122, which by inhibiting phospholipase C could affect vesicle formation and turnover. Staurosporine, despite its broad-spectrum kinase inhibition, may paradoxically promote the activation of HARE by preventing the action of kinases that negatively regulate endocytic pathways. In a similar vein, Epigallocatechin gallate (EGCG) serves to dampen competitive kinase signaling, thereby potentially creating a more favorable environment for HARE activity within its specialized endocytic domain. Collectively, these HARE Activators, through their nuanced and targeted effects on cellular signaling, provide the biochemical framework for the potential enhancement of HARE-mediated endocytic functions.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin increases intracellular cAMP levels, which can activate protein kinase A (PKA). PKA then phosphorylates various proteins that can lead to the activation of pathways in which HARE is involved, potentially enhancing HARE’s endocytic activity. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $162.00 $316.00 $559.00 $889.00 $1693.00 | 7 | |
D-erythro-Sphingosine-1-phosphate acts on its receptors to modulate signaling pathways, including those that regulate endocytosis and recycling of receptors, which could enhance the recycling capability of HARE and its associated endocytic functions. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $159.00 $315.00 $598.00 | 34 | |
IBMX is a non-specific inhibitor of phosphodiesterases, which increases cAMP and cGMP levels, thereby enhancing PKA and PKG activity. This can indirectly increase the endocytic activity of HARE through phosphorylation of proteins involved in clathrin-mediated endocytosis. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $26.00 $92.00 $120.00 $310.00 $500.00 $908.00 $1821.00 | 46 | |
Genistein inhibits tyrosine kinases, which may decrease competitive signaling pathways and allow for the enhanced activity of receptor-mediated endocytosis, a process in which HARE is directly involved. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
Phorbol 12-myristate 13-acetate (PMA) activates protein kinase C (PKC), which can phosphorylate proteins that regulate endocytosis and vesicle formation, potentially enhancing the functional activity of HARE in these processes. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY294002 is a PI3K inhibitor that could, by inhibiting competitive pathways, enhance the pathway in which HARE is involved, potentially increasing its activity in receptor-mediated endocytosis. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Wortmannin is another PI3K inhibitor that similarly to LY294002, may enhance HARE’s endocytic functionality by shifting the balance of signaling pathways. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $54.00 $128.00 $199.00 $311.00 | 23 | |
A23187 is an ionophore that increases intracellular calcium levels, activating calcium-dependent signaling pathways that are crucial for vesicle trafficking, potentially enhancing HARE's role in these processes. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
Staurosporine is a potent protein kinase inhibitor, which might lead to the selective activation of pathways in which HARE is involved by inhibiting kinases that negatively regulate HARE-associated processes. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
Thapsigargin disrupts calcium storage and enhances cytosolic calcium levels, which could activate calcium-dependent endocytic pathways, potentially enhancing the activity of HARE in these pathways. | ||||||